References
- Đorđević V, Rakićević L, Radojković D. An overview of genetic risk factors in thrombophilia. Srp Arh Celok Lek. 2010;138:79-81. DOI: 10.2298/SARH10S1079D
- Zhu XJ, Liu ZY, Wang PW, Wang J, Wen S Di, Zhang JX, et al. Congenital thrombophilia in East-Asian venous thromboembolism population: a systematic review and meta-analysis. Res Pract Thromb Haemost. 2023 Aug 1;7(6). DOI: 10.1016/j.rpth.2023.102157
- Montagnana M, Lippi G, Danese E. An overview of thrombophilia and associated laboratory testing. Hemostasis and Thrombosis: Methods and Protocols. 2017;113-35. DOI: 10.1007/978-1-4939-7196-1_9
- Elkattawy S, Alyacoub R, Singh KS, Fichadiya H, Kessler W. Prothrombin G20210A Gene Mutation-Induced Recurrent Deep Vein Thrombosis and Pulmonary Embolism: Case Report and Literature Review. J Investig Med High Impact Case Rep. 2022 Apr 1;10. DOI: 10.1177/23247096211058486
- Albagoush SA, Koya S, Chakraborty RK, Schmidt AE. Factor V leiden mutation. In: StatPearls [Internet]. StatPearls Publishing; 2023.
- Jadaon MM. Epidemiology of prothrombin G20210A mutation in the mediterranean region. Mediterr J Hematol Infect Dis. 2011;3(1). DOI: 10.4084/mjhid.2011.054
- Al-Zoubi N, Alrabadi N, Kheirallah K, Alqudah A. Prevalence and Multiplicity of Thrombophilia Genetic Polymorphisms of FV, MTHFR, F II, and PAI-I: A Cross-Sectional Study on a Healthy Jordanian Population. Int J Gen Med. 2021;5323-32. DOI: 10.2147/IJGM.S324340
- Vagdatli E, Serafimidou O, Pantziarela E, Tsikopoulou F, Mitsopoulou K, Papoutsi A. Prevalence of thrombophilia in asymptomatic individuals with a family history of thrombosis. Hippokratia. 2013;17(4):359.
- Athar M, Abduljaleel Z, Ghita IS, Albagenny AA, Halawani SH, Alkazmi MM, et al. Prevalence of the Factor V Leiden Mutation Arg534Gln in Western Region of Saudi Arabia: Functional Alteration and Association Study With Different Populations. Clinical and Applied Thrombosis/Hemostasis. 2021;27. DOI: 10.1177/1076029620978532
- Assaf N, Chamseddine F, Taher A, Mahfouz R. Prevalence of thrombophilia-associated mutations and their clinical significance in a large cohort of Lebanese patients. Meta Gene. 2021;29:100936. DOI: 10.1016/j.mgene.2021.100936
- Saour JN, Shoukri MM, Mammo LA. The Saudi Thrombosis and Familial Thrombophilia Registry: Design, Rationale, and Preliminary Results . Saudi Med J [Internet]. 2009;30(10):1286-90. Available from: www.smj.org.sa
- Dashti AA, Jadaon MM, Lewis HL. Factor v Leiden mutation in Arabs in Kuwait by real-time PCR: Different values for different Arabs. J Hum Genet. 2010 Apr;55(4):232-5. DOI: 10.1038/jhg.2010.11
- Hussein Mohamed Alfeel A, Hematology in. Association of Factor V-leiden and Prothrombin G20210A Mutations with Deep Venous Thrombosis in Patients attending Khartoum Hospitals, Khartoum State, Sudan (2013-2016). 2016.
- Madkhaly F, Alshaikh A, Alkhail HA, Alnounou R, Owaidah T. Prevalence of positive factor V Leiden and prothrombin mutations in samples tested for thrombophilia in Saudi Arabia. Am J Blood Res. 2021;11(3):255.
- Al-Otaiby M, Althnayan R, Binmethem A, AlEnezy RB, Alhadlg MA, Alaqeel A, et al. The prevalence of Factor V Leiden (Arg506Gln) mutation in King Khalid University Hospital patients, 2017-2019. Nagoya J Med Sci. 2021;83(3):407.
- Maalej L, Hadjkacem B, Ben Amor I, Smaoui M, Gargouri A, Gargouri J. Prevalence of factor V Leiden in south Tunisian blood donors. J Thromb Thrombolysis. 2011;32:116-9. DOI: 10.1007/s11239-011-0582-9
- Turki RF, Assidi M, Banni HA, Zahed HA, Karim S, Schulten HJ, et al. Associations of recurrent miscarriages with chromosomal abnormalities, thrombophilia allelic polymorphisms and/or consanguinity in Saudi Arabia. BMC Med Genet. 2016 Oct 10;17. DOI: 10.1186/s12881-016-0331-1
- Takhviji V, Zibara K, Maleki A, Azizi E, Hommayoun S, Tabatabaei M, et al. A case-control study on factor V Leiden: an independent, gender-dependent risk factor for venous thromboembolism. Thromb J. 2021;19:1-9. DOI: 10.1186/s12959-021-00328-0
- Tzoran I, Papadakis E, Brenner B, Valle R, López-Jiménez L, García-Bragado F, et al. Gender-related differences in the outcome of patients with venous thromboembolism and thrombophilia. Thromb Res. 2017;151:S11-5. DOI: 10.1016/S0049-3848(17)30060-9
- Zivelin A, Rosenberg N, Faier S, Kornbrot N, Peretz H, Mannhalter C, et al. A single genetic origin for the common prothrombotic G20210A polymorphism in the prothrombin gene. Blood, The Journal of the American Society of Hematology. 1998;92(4):1119-24. DOI: 10.1182/blood.V92.4.1119
- Rahimi Z, Vaisi-Raygani A, Mozafari H, Kharrazi H, Rezaei M, Nagel RL. Prevalence of factor V Leiden (G1691A) and prothrombin (G20210A) among Kurdish population from Western Iran. J Thromb Thrombolysis. 2008;25:280-3. DOI: 10.1007/s11239-007-0052-6
- Settin AA, Alghasham A, Ali A, Dowaidar M, Ismail H. Frequency of thrombophilic genetic polymorphisms among Saudi subjects compared with other populations. Hematology. 2012;17(3):176-82. DOI: 10.1179/102453312X13376952196575
- Alhumaydhi FA, Mackawy AMH, Morgan EN, Al Abdulmonem W, Alsagaby SA, Alwashmi ASS, et al. Potential role of folic acid in preventing male infertility associated with MTHFR gene C677T (rs1801133) polymorphism. All Life. 2021;14(1):730-43. DOI: 10.1080/26895293.2021.1963846
- AlGasham A, Ismail H, Dowaidar M, Settin AA. Methylenetetrahydrofolate Reductase (MTHFR) and Angiotensin Converting Enzyme (ACE) Gene Polymorphisms among Saudi Population from Qassim Region. Int J Health Sci (Qassim). 2011;5(2 Suppl 1):3.
- Bagher AM, Young AP, Neamatallah T, Al-Amoudi RM, Bagher SM, Denovan-Wright EM. Prevalence of methylenetetrahydrofolate reductase gene polymorphisms (C677T, and A1298C) among Saudi children receiving dental treatment. Ann Saudi Med. 2021;41(1):1-7. DOI: 10.5144/0256-4947.2021.1
- Eloualid A, Abidi O, Charif M, El Houate B, Benrahma H, Louanjli N, et al. Association of the MTHFR A1298C variant with unexplained severe male infertility. PLoS One. 2012;7(3):e34111. DOI: 10.1371/journal.pone.0034111